The Invisible Threat: How PFAS and Micro/Nano Plastics Embed in Your Tissues – And Why INUSpheresis® Is a Targeted Solution for Deep Detox
The Invisible Threat: PFAS and Micro/Nano Plastics in Your Tissues – And Why INUSpheresis® Offers a Targeted Solution
At ZIV, we help clients access advanced regenerative therapies that address the root causes of chronic inflammation and toxin overload. One of the most pressing modern health challenges is the widespread accumulation of per- and polyfluoroalkyl substances (PFAS) — the so-called “forever chemicals” — and micro- and nanoplastics (MNPs). These persistent pollutants are now documented in nearly every human tissue and organ.
You are not powerless against them. INUSpheresis®, a highly selective double-filtration plasmapheresis therapy available through ZIV’s exclusive partner clinics, has been shown in peer-reviewed case studies to physically remove these particles and related toxins from the bloodstream while returning your own purified plasma.
What Are PFAS and Micro/Nano Plastics?
PFAS are a large family of synthetic chemicals used in non-stick cookware, water-repellent fabrics, food packaging, firefighting foams, and countless consumer products. They are extremely stable and do not break down easily in the environment or the body.
Microplastics (particles <5 mm) and nanoplastics (<1 μm) result from the breakdown of plastic waste, synthetic textiles, tire wear, and everyday products. They are ubiquitous in air, water, food, and dust.
Both classes of contaminants share two critical traits: extreme persistence and bioaccumulation.
How These Toxins Enter and Embed in Human Tissues
Exposure occurs daily through:
Ingestion (contaminated food, water, and packaging)
Inhalation (indoor/outdoor air and dust)
Dermal absorption (personal care products and textiles)
Once inside the body, PFAS bind strongly to proteins (especially serum albumin) and accumulate preferentially in blood, liver, kidneys, thyroid, and reproductive tissues. Their half-lives in humans range from several years (e.g., PFOA ~3.5 years, PFOS ~4.8 years).
Micro- and nanoplastics cross biological barriers even more readily. They have been detected in:
Blood
Placenta and umbilical cord blood
Lung tissue
Liver
Brain (including in dementia cases)
Heart muscle and carotid artery plaques
Semen and breast milk
Studies using advanced imaging and spectroscopy confirm these particles embed in cells, tissues, and even cross the blood-brain barrier.
Because of their small size and chemical stability, the body’s natural detoxification pathways (liver and kidneys) are often insufficient to clear them efficiently. They build up over years, creating a lifelong internal burden.
The Documented Health Dangers
Peer-reviewed research now links chronic exposure to serious, multi-system effects:
PFAS
Immune dysregulation and reduced vaccine response
Thyroid and metabolic disruption (altered cholesterol, diabetes risk)
Reproductive and developmental toxicity
Liver and kidney damage
Increased cancer risk (kidney and testicular cancers have the strongest evidence)
Cardiovascular and endocrine effects
Major reviews by the EPA, ATSDR, and independent scientists consistently show dose-dependent associations across large population studies.
Micro/Nano Plastics
Systemic inflammation and oxidative stress
Cardiovascular risk — a 2024 New England Journal of Medicine study found patients with microplastics in carotid artery plaques had significantly higher rates of heart attack, stroke, and death.
Reproductive toxicity (reduced sperm quality, presence in placenta)
Neuroinflammation and potential links to neurodegenerative conditions
Gut dysbiosis, liver enzyme elevation, and immune activation
Recent human tissue studies (2024–2026) confirm widespread distribution and correlation with inflammatory markers and functional impairment.
You do not have to live with this accumulating burden. These toxins are removable.
The INUSpheresis® Solution: Selective Double-Filtration Plasmapheresis
INUSpheresis® (a refined form of double-filtration plasmapheresis or DFPP) uses two specialized membranes in a closed-loop system. It selectively captures large-molecule toxins, immune complexes, cytokines, micro- and nanoplastics, PFAS, heavy metals, and other environmental pollutants — while preserving ~75% of albumin and ~59% of globulins and returning your own purified plasma.
Unlike standard therapeutic plasma exchange (TPE), which discards plasma and requires expensive replacement fluids, INUSpheresis® is:
Closed-loop (no donor plasma or albumin needed)
Highly selective (broader toxin spectrum)
Gentler (~0.7% mild side effects vs. 8–15% for TPE)
Clinical Evidence: INUSpheresis® Removes These Particles
Peer-reviewed studies demonstrate its effectiveness:
Scholkmann & Gatti (2022) used field-emission scanning electron microscopy (FE-SEM/EDX) on INUSpheresis® eluate and confirmed the presence and removal of nano- and microparticles, including plastic-derived and metal-containing particulates.
Castillo-Aleman et al. (2025) showed DFPP effectively removes a wide range of environmental toxins (including lipophilic and protein-bound compounds) in patients, with high capture rates for persistent pollutants.
Bornstein et al. (2025) provided the first direct evidence that therapeutic apheresis (specifically INUSpheresis®) removes MNP-like particles from patients with post-infectious syndromes.
Additional case series document significant reductions in heavy metals, pesticides, and other persistent toxins, with measurable clinical improvements in inflammation and symptoms.
You Don’t Have to Live This Way
Modern life exposes us to these toxins daily, but advanced blood purification gives your body a powerful reset. ZIV’s concierge model makes world-class INUSpheresis® accessible with full support:
Ready to take control of your toxin burden? Contact ZIV for a consultation. Our team will map a personalized protocol tailored to your health goals.